Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials
Rebecca Ichord1, Faye S Silverstein2, Beth S Slomine2
1From the Department of Neurology & Pediatrics (R.I.), Children's Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania; University of Michigan (F.S.S., F.W.M.), Ann Arbor; Kennedy Krieger Institute and Johns Hopkins University (B.S.S., J.C.), Baltimore, MD; and University of Utah (R.T., R.H., J.M.D.), Salt Lake City. ichord@email.chop.edu.
Insights
A new tool, the Pediatric Resuscitation after Cardiac Arrest (PRCA) form, effectively assesses neurologic outcomes in pediatric cardiac arrest survivors. This method shows strong correlation with existing measures, aiding in understanding long-term recovery.
Area of Science:
- Pediatric critical care medicine
- Neurology
- Clinical trial methodology
Background:
- Pediatric cardiac arrest (CA) survivors often experience significant neurologic deficits.
- Standardized assessment of neurologic outcomes is crucial for evaluating interventions like therapeutic hypothermia.
- Previous assessments lacked a comprehensive, semi-quantitative tool for detailed neurologic characterization.
Purpose of the Study:
- To implement and validate the Pediatric Resuscitation after Cardiac Arrest (PRCA) form for characterizing neurologic outcomes in pediatric CA survivors.
- To assess the correlation of the PRCA form with established neurobehavioral and cognitive measures at 12 months post-arrest.
Main Methods:
- Two multicenter trials (THAPCA-OH and THAPCA-IH) enrolled comatose pediatric CA survivors randomized to therapeutic hypothermia or normothermia.
- Neurologists assessed 181 12-month survivors using the novel PRCA form, rating neurologic impairment across 6 domains.
- PRCA scores were compared with 12-month Vineland Adaptive Behavior Scales (VABS-II) and cognitive scores.
Main Results:
- The PRCA form classified neurologic outcomes into 5 categories, from no/minimal to profound impairment.
- PRCA scores demonstrated strong correlations with VABS-II (r = -0.88) and cognitive scores (r = -0.72), indicating robust validity.
- Factors associated with poor outcomes included out-of-hospital CA and early seizure recognition.
Conclusions:
- The PRCA form is a validated and robust method for assessing neurologic impairment after pediatric CA.
- This tool provides a global, semi-quantitative rating and domain-specific information, valuable for research and clinical practice.
- The PRCA's strong correlation with established measures supports its utility across diverse pediatric CA outcomes.
Objective:
To implement a standardized approach to characterize neurologic outcomes among 12-month survivors in the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials.
Methods:
Two multicenter trials enrolled children age 48 hours to 18 years who remained comatose after cardiac arrest (CA) occurring out-of-hospital (THAPCA-OH, NCT00878644) or in-hospital (THAPCA-IH, NCT00880087); patients were randomized to therapeutic hypothermia or therapeutic normothermia. The primary outcome, survival with favorable 12-month neurobehavioral outcome (Vineland Adaptive Behavior Scales [VABS-II]), did not differ between treatment groups in either trial. Neurologists examined 181 12-month survivors, described findings using the novel semi-quantitative Pediatric Resuscitation after Cardiac Arrest (PRCA) form, and rated findings in 6 domains; scores ranged from 0 (no deficits) to 21 (maximal deficits). PRCA scores were compared with 12-month VABS-II scores and cognitive scores.
Results:
Neurologic outcome PRCA scores were classified as no/minimal impairment, PRCA 0-3, 81/179 (45%); mild impairment, PRCA 4-7, 24/179 (13%); moderate impairment, PRCA 8-11, 15/179 (8%); severe impairment, PRCA 12-16, 20/179 (11%); profound impairment, PRCA 17-21, 39/179 (21%) (2/181 incomplete). VABS-II scores correlated strongly with PRCA category (r = -0.88, p < 0.0001, Pearson correlation coefficient) and cognitive scores (r = -0.72, p < 0.0001). Factors associated with poor outcomes included out-of-hospital CA, seizure recognition in the early postarrest period, and poor neurologic status at hospital discharge.
Conclusion:
The PRCA provides a robust method for depicting neurologic outcomes after acute encephalopathy caused by CA in children. It provides a global semiquantitative rating of neurologic impairment and domain-specific impairment. The strong correlation with well-established neurobehavioral outcome measures supports its validity over a broad age range and wide spectrum of outcomes.
Related Concept Videos
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...

